Luke Sergott
Stock Analyst at Barclays
(2.39)
# 2,615
Out of 5,038 analysts
331
Total ratings
47.76%
Success rate
-2.86%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Maintains: Overweight | $225 → $250 | $218.10 | +14.63% | 41 | Oct 22, 2025 | |
| A Agilent Technologies | Maintains: Equal-Weight | $125 → $150 | $145.87 | +2.83% | 12 | Oct 2, 2025 | |
| AVTR Avantor | Maintains: Overweight | $13 → $15 | $15.16 | -1.06% | 26 | Oct 2, 2025 | |
| BRKR Bruker | Maintains: Overweight | $43 → $40 | $38.95 | +2.70% | 6 | Oct 2, 2025 | |
| CERT Certara | Maintains: Overweight | $14 → $16 | $12.72 | +25.79% | 18 | Oct 2, 2025 | |
| EXAS Exact Sciences | Maintains: Overweight | $55 → $65 | $62.91 | +3.32% | 7 | Oct 2, 2025 | |
| FTRE Fortrea Holdings | Maintains: Underweight | $6 → $8 | $10.52 | -23.95% | 12 | Oct 2, 2025 | |
| GH Guardant Health | Maintains: Overweight | $60 → $70 | $68.03 | +2.90% | 4 | Oct 2, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Equal-Weight | $180 → $190 | $192.60 | -1.35% | 21 | Oct 2, 2025 | |
| ILMN Illumina | Maintains: Underweight | $90 → $95 | $97.23 | -2.29% | 20 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $185 → $200 | $217.86 | -8.20% | 24 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1,325 → $1,350 | $1,381.44 | -2.28% | 2 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 → $53 | $48.60 | +9.05% | 2 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $150 → $160 | $157.41 | +1.65% | 2 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $95.68 | +4.52% | 10 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $19 | $16.75 | +13.43% | 22 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $550 → $585 | $567.20 | +3.14% | 28 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $45 → $40 | $31.06 | +28.78% | 18 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $260 → $275 | $277.00 | -0.72% | 3 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $450 → $425 | $546.74 | -22.27% | 3 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $165 → $195 | $187.00 | +4.28% | 9 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $190 → $210 | $188.02 | +11.69% | 4 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $15 | $12.26 | +22.35% | 13 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $88.06 | +2.20% | 1 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2 → $1.5 | $1.84 | -18.48% | 5 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $400 → $350 | $348.67 | +0.38% | 18 | Apr 10, 2025 |
Danaher
Oct 22, 2025
Maintains: Overweight
Price Target: $225 → $250
Current: $218.10
Upside: +14.63%
Agilent Technologies
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $125 → $150
Current: $145.87
Upside: +2.83%
Avantor
Oct 2, 2025
Maintains: Overweight
Price Target: $13 → $15
Current: $15.16
Upside: -1.06%
Bruker
Oct 2, 2025
Maintains: Overweight
Price Target: $43 → $40
Current: $38.95
Upside: +2.70%
Certara
Oct 2, 2025
Maintains: Overweight
Price Target: $14 → $16
Current: $12.72
Upside: +25.79%
Exact Sciences
Oct 2, 2025
Maintains: Overweight
Price Target: $55 → $65
Current: $62.91
Upside: +3.32%
Fortrea Holdings
Oct 2, 2025
Maintains: Underweight
Price Target: $6 → $8
Current: $10.52
Upside: -23.95%
Guardant Health
Oct 2, 2025
Maintains: Overweight
Price Target: $60 → $70
Current: $68.03
Upside: +2.90%
ICON Public Limited Company
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $180 → $190
Current: $192.60
Upside: -1.35%
Illumina
Oct 2, 2025
Maintains: Underweight
Price Target: $90 → $95
Current: $97.23
Upside: -2.29%
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $185 → $200
Current: $217.86
Upside: -8.20%
Oct 2, 2025
Maintains: Overweight
Price Target: $1,325 → $1,350
Current: $1,381.44
Upside: -2.28%
Oct 2, 2025
Maintains: Overweight
Price Target: $55 → $53
Current: $48.60
Upside: +9.05%
Oct 2, 2025
Maintains: Overweight
Price Target: $150 → $160
Current: $157.41
Upside: +1.65%
Oct 2, 2025
Maintains: Overweight
Price Target: $110 → $100
Current: $95.68
Upside: +4.52%
Oct 2, 2025
Maintains: Overweight
Price Target: $17 → $19
Current: $16.75
Upside: +13.43%
Oct 2, 2025
Maintains: Overweight
Price Target: $550 → $585
Current: $567.20
Upside: +3.14%
Oct 2, 2025
Maintains: Overweight
Price Target: $45 → $40
Current: $31.06
Upside: +28.78%
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $260 → $275
Current: $277.00
Upside: -0.72%
Oct 2, 2025
Downgrades: Underweight
Price Target: $450 → $425
Current: $546.74
Upside: -22.27%
Oct 2, 2025
Upgrades: Overweight
Price Target: $165 → $195
Current: $187.00
Upside: +4.28%
Aug 8, 2025
Maintains: Overweight
Price Target: $190 → $210
Current: $188.02
Upside: +11.69%
Aug 8, 2025
Maintains: Overweight
Price Target: $13 → $15
Current: $12.26
Upside: +22.35%
Aug 1, 2025
Initiates: Overweight
Price Target: $90
Current: $88.06
Upside: +2.20%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $2 → $1.5
Current: $1.84
Upside: -18.48%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $400 → $350
Current: $348.67
Upside: +0.38%